Deval L. Patrick serves as Executive at Global Blood Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Deval L. Patrick has executed 54 insider transactions totaling $5.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 25, 2017 involved exercising options for 12,053 shares valued at $41.0K.
Deval L. Patrick currently holds 17,654 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deval L. Patrick has been a net seller of GBT stock. They have purchased $314.7K and sold $5.2M worth of shares.
Deval L. Patrick's most recent insider trade was on Jul 25, 2017, when they sold 12,053 shares at $3.40 per share.
Get notified when new Form 4 filings are submitted
| 15,000 |
| $18.85 |
| Discretionary |
| Jul 25, 2017 | GBT | $803.2K | Sale | 27,053 | $29.69 | Discretionary |
| Aug 17, 2015 | GBT | $50.0K | Purchase | 2,500 | $20.00 | Discretionary |